Th17 cells can be expanded ex vivo with anti-CTLA-4 from CD4+ T-cells and whole PBMCs isolated from anti-CTLA-4-treated metastatic melanoma patients [93,108]. This evidence concerns the gene CTLA4 and metastatic melanoma.